Evaluation of the effects of galbanic acid from Ferula szowitsiana and conferol from F. badrakema, as modulators of multi-drug resistance in clinical isolates of Escherichia coli and Staphylococcus aureus

Research in Pharmaceutical Sciences

Volumn 5, Issue 1, 2010, Pages 25-32

  Fazly Bazzaz, B S ^a   Iranshahi, M ^a   Naderinasab, M ^b   Hajian, S ^a   Sabeti, Z ^a   Masumi, E ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Conferol; Escherichia coli; Ferula; Galbanic acid; Multi drug resistance; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; CONFEROL; ETHIDIUM BROMIDE; GALBANIC ACID; METICILLIN; SESQUITERPENE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; FERULA BADRAKEMA; FERULA SZOWITSIANA; GRAM NEGATIVE BACTERIUM; LIPOPHILICITY; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OUTER MEMBRANE; STAPHYLOCOCCUS AUREUS;

EID: 78650638466     PISSN: 17355362     EISSN: 17359414     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Marquez B. Bacterial efflux systems and efflux pumps inhibitors. Biochimie. 2005; 87: 1137-1147.
2. Langton KP, Henderson PJF, Herbert RB. Antibiotic resistance: multidrug efflux proteins, a common transport mechanism? Nat Prod Rep. 2005; 22: 439-451.
3. Mullin S, Mani N, Grossman TH. Inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (VX-710) and timcodar (VX-853). Antimicrob Agents Chemother. 2004; 48: 4171-4176.
4. Stavri M., Piddock LJ, Gibbons S. Bacterial efflux pump inhibitors from natural sources. J Antimicrob Chemother. 2007; 59: 1247-1260.
5. Couto I, Costa SS, Viveiros M, Martins M, Amaral L. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide. J Antimicrob Chemother. 2008; 62: 504-513.
6. Piddock LJ. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev. 2006; 19: 382-402.
7. Lomovskaya O, Watkins WJ. Efflux pumps: their role in antibacterial drug discovery. Current Med Chem. 2001; 8: 1699-1711.
8. Abd El-Razek MH, Ohta S, Hirata T. Terpenoid coumarins of the genus Ferula. Heterocycles. 2003; 60: 689-716.
9. Brehm-Stecher BF, Johnson EA. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob Agents Chemother. 2003; 47: 3357-3360.
10. Madureira AM, Molnar A, Abreu PM, Molnar J, Ferreira MJ. A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein. Planta Med. 2004; 70: 828-833.
11. Iranshahi M, Arfa P, Ramezani M, Jaafari MR, Sadeghian H, Bassarello C, et al. Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochem. 2007; 68: 554-561.
12. Rassouli FB, Matin MM, Iranshahi M, Bahrami AR, Neshati V, Mollazadeh S, et al. Mogoltacin enhances vincristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. Phytomedicine. 2009; 16: 181-187.
13. Zgoda JR, Porter JR. A convenient microdilution method for screening natural products against bacteria and fungi. Pharmaceut Biol. 2001; 39: 221-225.
14. Kuroda M, Nagasaki S, Ohta T. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to β-lactams in methicillinresistant Staphylococcus aureus. J Antimicrob Chemother. 2007; 59: 425-432.
15. Andrews JM, Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001; 48: 5-16.
16. Eloff JN. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998; 64: 711-713.
17. Sato M, Tanaka H, Yamaguchi R, Kato K, Etoh H. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus. IJAA. 2004; 24: 241-246.
18. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Wayne: NCCLS Publisher; 2004. 14th informational supplement. M100-S14.
19. Gibbons S, Oluwatuyi M, Kaatz GW. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J Antimicrob Chemother. 2003; 51: 13-17.
20. Zioh M, Kaatz GW, Gibbons S. Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. Bioorg Med Chem Lett. 2004; 14: 881-885.
21. Shahverdi AR, Fakhimi A, Zarrini G, Dehghan G, Iranshahi M. Galbanic acid from Ferula szowitsiana enhanced the antibacterial activity of penicillin G and cephalexin against Staphylococcus aureus. Biol Pharm Bull. 2007; 30: 1805-1807.
22. Fazly Bazzaz BS, Memariani Z, Khashiarmanesh Z, Iranshahi M, Naderinasab M. Effect of galbanic acid, a sesquiterpene coumarin from Ferula szowitsiana, as an inhibitor of efflux mechanism in resistant clinical isolates of Staphylococcus aureus. Braz J Microbiol. 2010; 41: 574-580.
23. Fazly Bazzaz BS, Rezaei Du A, Iranshahi M, Naderinasab M, Khajeh Karamadini M.. Evaluating the potentiating effect of galbanic acid from Ferula szowitsiana on three common antibiotics against resistant hospital isolates of Staphylococcus aureus. Iran J Pharm Res. 2009; 8: 217-221.
24. Aeschlimann JR, Dresser LD, Kaatz GW, Rybak MJ. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother. 1999; 43: 335-340.